Marchex Completes Archenia Acquisition, Issues $10M Convertible Notes
MCHX sits 27% above its 52-week low of $1.322.
Summary
Marchex completed its acquisition of Archenia, a key strategic move involving $10 million in convertible notes and up to 4 million performance shares, following strong shareholder approval.
Key Events · M&A and Partnerships · MCHX
-
Acquisition Finalized
Marchex completed the acquisition of Archenia, a performance-based marketing technology company, on July 1, 2026. This follows the definitive agreement announced on May 12, 2026.
-
Consideration Details
The acquisition involved the issuance of $10 million in 6% convertible promissory notes to the sellers, convertible into Class B common stock at $1.80 per share. Additionally, up to 4 million performance-based shares of Class B common stock may be issued over two years.
-
Shareholder Approval
Shareholders overwhelmingly approved the acquisition at a special meeting on July 1, 2026, with approximately 99.9% approval under both the simple majority and majority of the minority votes.
-
Related-Party Transaction
The sellers of Archenia included Marchex's Chairman and Vice Chairman, making it a related-party transaction. The strong 'majority of the minority' shareholder vote mitigates concerns regarding potential conflicts of interest.
Analysis · MCHX · Technology
Marchex has finalized its acquisition of Archenia, a performance-based marketing technology company, a strategic move previously announced and approved by shareholders. The deal involves $10 million in convertible notes, with a conversion price of $1.80 per share (above the current market price), and up to 4 million performance-based shares. This acquisition represents a significant expansion for Marchex, integrating AI-driven customer qualification technology. The shareholder approval, including a majority of minority shareholders, validates the transaction despite it being a related-party deal.
At the time of this filing, MCHX was trading at $1.68 on NASDAQ in the Technology sector, with a market capitalization of approximately $74.5M. The 52-week trading range was $1.32 to $2.27. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.